Back to search

National and Kapodistrian University of Athens

Ποσοτικοποίηση του HIV-DNA σε μονοπύρηνα κύτταρα περιφερικού αίματος (PBMCs) φορέων της HIV λοίμωξης

Abstract

dc:description

The rate of HIV-1 disease progression varies greatly among HIV-1-infected individuals, depending on several factors, such as baseline HIV RNA level, baseline CD4⁺ T-cell level, age at seroconversion, gender, etc. Quantification of HIV-RNA in plasma has routinely been used for assessment of the efficacy of HAART, and it provides a strong predictor of HIV-1 disease progression. The introduction of HAART in clinical practice increased the life expectancy and life quality of HIV-infected patients. Treatment with HAART allows a drastic reduction of the plasma HIV-RNA load, to such an extent that circulating HIV-1 in plasma becomes undetectable (<50 copies/ml) by the most sensitive viral detection assays. Given the drastic reduction of HIV-RNA level in plasma, a new prognostic marker was found, the levels of HIV-1 DNA in PBMCs, which can be used as a prognostic marker for HIV-1 infection. Moreover, in patients with undetectable HIV-RNA level, HIV-1 DNA consists the only marker of viral replication in PBMCs and lymphoid tissues. Several studies have demonstrated that HIV-1 DNA levels can be used as an independed prognostic marker in clinical practice for HIV-infected patients’ management, for disease progression, for optimizing therapy initiation, predicting treatment outcome and long-term success of HAART. The purpose of this study was to investigate the importance of HIV-1 DNA quantification in HIV-infected patients. For this purpose, we review all previously reported assays for HIV-1 DNA quantification as well all the studies investigating its role as an additional marker in HIV-infection and treatment initiation and outcome. Given the fact that there is not a commercially available assay for HIV-1 DNA, we develop an in house real-time PCR assay for HIV-1 DNA quantification in multiplex format with CCR5 reporter gene. The molecular beacon based multiplex real-time PCR assay was developed in LightCycler 2.0® apparatus. Thereafter the multiplex assay was performed in 115 randomly selected patients before HAART initiation, in order to find correlations of HIV-1 DNA baseline level with two other prognostic markers (HIV-RNA and CD4 T-cells count. Finally, a study protocol was set up in order to investigate whether HIV-1 DNA is a prognostic factor of the first line treatment.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Μπελούκας, Απόστολος
  • Beloukas, Apostolos

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/31584

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Μπελούκας, Απόστολος; Beloukas, Apostolos. Ποσοτικοποίηση του HIV-DNA σε μονοπύρηνα κύτταρα περιφερικού αίματος (PBMCs) φορέων της HIV λοίμωξης. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/31584